Source:http://linkedlifedata.com/resource/pubmed/id/11601132
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2001-10-16
|
pubmed:abstractText |
In tissue sections, thyroid transcription factor-1 (TTF-1) is a sensitive marker for adenocarcinomas of lung and thyroid origin. This immunohistochemical study evaluates the effectiveness of TTF-1 as a marker for pulmonary adenocarcinomas in paraffin sections of cell block preparations derived from effusion and fine-needle aspiration specimens. We evaluated 122 cell blocks including 8 primary and 39 metastatic pulmonary adenocarcinomas, 11 pulmonary neoplasms of other types, 50 specimens with nonpulmonary metastatic tumors, and 14 mesotheliomas. TTF-1 was reactive in 42 (89%) of 47 pulmonary adenocarcinomas. Only 1 of 4 pulmonary small cell/neuroendocrine tumors was TTF-1 positive, while 1 of 7 squamous cell carcinomas was weakly reactive. Of 50 metastatic tumors of nonpulmonary origin, focal weak reactivity was noted only for 1 metastatic ovarian carcinoma. All mesotheliomas were nonreactive. In cytologic preparations, TTF-1 is a highly selective marker for pulmonary adenocarcinoma and also can have a role in the distinction between pulmonary adenocarcinoma and mesothelioma.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0002-9173
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
116
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
483-8
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11601132-Adenocarcinoma,
pubmed-meshheading:11601132-Biopsy, Needle,
pubmed-meshheading:11601132-Carcinoma, Neuroendocrine,
pubmed-meshheading:11601132-Carcinoma, Squamous Cell,
pubmed-meshheading:11601132-Diagnosis, Differential,
pubmed-meshheading:11601132-Humans,
pubmed-meshheading:11601132-Immunohistochemistry,
pubmed-meshheading:11601132-Lung Neoplasms,
pubmed-meshheading:11601132-Mesothelioma,
pubmed-meshheading:11601132-Neoplasm Metastasis,
pubmed-meshheading:11601132-Nuclear Proteins,
pubmed-meshheading:11601132-Sensitivity and Specificity,
pubmed-meshheading:11601132-Transcription Factors,
pubmed-meshheading:11601132-Tumor Markers, Biological
|
pubmed:year |
2001
|
pubmed:articleTitle |
The value of thyroid transcription factor-1 in cytologic preparations as a marker for metastatic adenocarcinoma of lung origin.
|
pubmed:affiliation |
Department of Pathology, Brigham & Women's Hospital, 75 Francis St, Boston, MA 02115, USA.
|
pubmed:publicationType |
Journal Article
|